Transplant International

Papers
(The TQCC of Transplant International is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Malignancy among adult heart transplant recipients following patient‐tailored dosing of anti‐thymocyte globulin: a retrospective, nested case‐control study of individualized dosing81
Cardiorespiratory fitness in kidney transplant recipients compared to patients with kidney failure: a systematic review and meta‐analysis65
Endoscopic ultrasound guided portal‐systemic pressure gradient measurement to determine candidacy for kidney transplant alone versus combined liver kidney transplant in patients with advanced fibrosis39
Transplant Trial Watch35
Consensus statement on normothermic regional perfusion in donation after circulatory death: Report from the European Society for Organ Transplantation’s Transplant Learning Journey35
Glucagon‐like peptide‐1 receptor agonists and sodium‐glucose cotransporter 2 inhibitors for diabetes after solid organ transplantation33
30
Acknowledgements to reviewers28
27
Implementation of the kidney team at home intervention: Evaluating generalizability, implementation process, and effects27
Assessment of the global practice of living donor liver transplantation27
Kidney transplant outcomes in elderly recipients with controlled donation after circulatory death or donation after brain death donors: a registry cohort study26
Postoperative delirium in kidney transplant patients23
Outcome of pretransplant melanoma after solid organ transplantation: an observational study19
Determinants of increased thrombotic tendency in NASH cirrhosis: not there yet!18
Diagnostic and therapeutic management algorithm for biliary complications in living liver donors17
Early detection of SARS‐CoV‐2 and other infections in solid organ transplant recipients and household members using wearable devices17
Human liver stem cell‐derived extracellular vesicles reduce injury in a model of normothermic machine perfusion of rat livers previously exposed to a prolonged warm ischemia16
Inferior outcomes in young adults undergoing liver transplantation – a UK and Ireland cohort study16
Donation after circulatory death and liver transplantation: a cohort study16
16
Deciphering transplant outcomes of expanded kidney allografts donated after controlled circulatory death in the current transplant era. A call for caution15
Changes in consent rate, expressed deceased donation decision‐making, and family interactions in Israel—a national retrospective cohort study15
Significance and clinical impact of routinely tested urinary ethyl glucuronide after liver transplantation – development of a risk score15
Bisphosphonate therapy after liver transplant improves bone mineral density and reduces fracture rates: an updated systematic review and meta‐analysis14
Autologous regulatory T cells in clinical intraportal allogenic pancreatic islet transplantation14
To screen or not to screen? The development of a prediction model for aorto‐iliac stenosis in kidney transplant candidates14
Transplant Trial Watch14
Have we reached the limits in altruistic kidney donation?14
The Liver Retransplantation Risk Score: a prognostic model for survival after adult liver retransplantation13
The Glissonian stitch traction for biliary duct manipulation in living donor liver transplantation13
Clinical value and limitations of the preoperative C‐reactive‐protein‐to‐albumin ratio in predicting post‐operative morbidity and mortality after deceased‐donor liver transplantation: a retrospective 13
Author Index13
High trough levels of everolimus combined to sorafenib improve patients survival after hepatocellular carcinoma recurrence in liver transplant recipients13
Recurrent proteinuria with graft dysfunction: a diagnostic and clinical conundrum13
SARS‐CoV‐2 vaccination in solid‐organ transplant recipients: What the clinician needs to know12
Therapeutic education as a tool to improve patient‐reported and clinical outcomes after renal transplantation: results of the EPHEGREN multicenter retrospective cohort study12
Is transplantation per se a risk factor for worse outcome of SARS–CoV–2 infection in kidney transplant recipients?12
Functional roles of graft‐infiltrating lymphocytes during early‐phase post‐transplantation in mouse cardiac transplantation models12
Application of ischaemia‐free liver transplantation improves prognosis of patients with steatotic donor livers – a retrospective study12
Cancer transmissions and non‐transmissions from solid organ transplantation in an Australian cohort of deceased and living organ donors12
Usefulness of an organ donation opinion survey as a tool to promote organ donation among the adolescent population12
Liver transplantation for congenital hepatic fibrosis11
Short‐ and long‐term impact of neutropenia within the first year after kidney transplantation10
Kidney paired donation is necessary in Brazil10
Transplant Trial Watch10
Transplant Trial Watch10
Oral presentations10
Is simplification of immunosuppressive medication a way to promote medication adherence of kidney transplant recipients? Findings from a randomized controlled trial10
Program10
An analysis of the outcomes in living donor liver transplantation for pediatric malignant hepatic tumors using nationwide survey data in Japan9
Islet transplantation in the United States – Quo Vadis? An interview with Camilo Ricordi (CR), Ali Naji (AN), Peter Stock (PS), Piotr Witkowski (PW)9
Delayed introduction of sirolimus in paediatric intestinal transplant recipients: indications and long‐term benefits9
A kidney discard decision strategy based on zero‐time histology analysis could lead to an unjustified increase in the organ turndown rate among ECD9
Short‐ and long‐term results of liver transplantation according to age at transplant: a single‐center experience of 351 children9
Recurrent proteinuria with graft dysfunction: a diagnostic and clinical conundrum9
A meta‐analysis of the cumulative incidence, risk factors, and clinical outcomes associated with chronic kidney disease after liver transplantation9
Type of proton‐pump inhibitor and risk of iron deficiency in kidney transplant recipients – results from the TransplantLines Biobank and Cohort Study9
Recurrence of primary sclerosing cholangitis after liver transplantation – analysing the European Liver Transplant Registry and beyond9
Impact of recipient and donor smoking in living‐donor kidney transplantation: a prospective multicenter cohort study9
0.22052097320557